Qiagen taps CEO, ships coronavirus tests to U.S.

By LabPulse.com staff writers

March 24, 2020 -- Qiagen has made it official: Thierry Bernard has been named the company's permanent CEO after serving in an interim capacity since October 2019.

Thierry Bernard
Thierry Bernard. Image courtesy of Qiagen.

Bernard was named interim CEO after the departure of Peer Schatz in October. Bernard had previously been the head of Qiagen's molecular diagnostics business.

In announcing the move, Qiagen chairman Håkan Björklund said that in his term as interim CEO, Bernard had demonstrated "energy and skill" in driving Qiagen forward, and he has been a key leader in the agreement for Qiagen to be acquired by Thermo Fischer Scientific. That deal is scheduled to be completed in the first half of 2021.

In other company news, Qiagen said it has begun shipping its panel test for the SARS-CoV-2 novel coronavirus to the U.S. Qiagen's QIAstat-Dx respiratory SARS-CoV-2 panel takes less than one minute to prepare, and results can be returned in less than an hour, according to the company. The test differentiates the SARS-CoV-2 coronavirus from 20 other respiratory infections, according to the company. Qiagen said it plans to submit an emergency use authorization for the test to the U.S. Food and Drug Administration this week.

Qiagen boosts RNA extraction kit production
Qiagen is boosting its global production capacity for RNA nucleic extraction kits for use in detecting the novel coronavirus.
Qiagen, NuProbe partner on next-generation sequencing liquid biopsy
Qiagen and molecular diagnostics company NuProbe have entered into an agreement to develop noninvasive liquid biopsy tests for cancer diagnosis using...
Qiagen gets $598K to make syndromic COVID-19 test
The U.S. Department of Health and Human Services will contribute $598,000 to Qiagen to develop a test kit to detect the genetic material of SARS-CoV-2,...
Thermo Fisher set to acquire Qiagen after all in $11.5B deal
After an on-and-off courtship, Thermo Fisher Scientific announced it is set to acquire Qiagen in a deal worth $11.5 billion. The transaction will...
Qiagen ships coronavirus test kits
Qiagen has shipped test kits for the novel coronavirus now known as SARS-CoV-2 to four hospitals in China, and it is in the process of shipping tests...

Copyright © 2020 LabPulse.com

Last Updated np 3/25/2020 4:46:00 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email